Drug Shortage Report for TARO-TESTOSTERONE CYPIONATE INJECTION

Last updated on 2025-12-01 History
Report ID 242561
Drug Identification Number 02496003
Brand name TARO-TESTOSTERONE CYPIONATE INJECTION
Common or Proper name Testosterone
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TESTOSTERONE CYPIONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 10 mL
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-01
Estimated end date 2025-11-21
Actual end date 2025-11-25
Shortage status Resolved
Updated date 2025-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v40 2025-12-01 French Compare
v39 2025-12-01 English Compare
v38 2025-11-19 French Compare
v37 2025-11-19 English Compare
v36 2025-11-11 French Compare
v35 2025-11-11 English Compare
v34 2025-10-07 French Compare
v33 2025-10-07 English Compare
v32 2025-09-29 French Compare
v31 2025-09-29 English Compare
v30 2025-09-15 French Compare
v29 2025-09-15 English Compare
v28 2025-09-02 French Compare
v27 2025-09-02 English Compare
v26 2025-08-18 French Compare
v25 2025-08-18 English Compare
v24 2025-07-18 French Compare
v23 2025-07-18 English Compare
v22 2025-07-07 French Compare
v21 2025-07-07 English Compare

Showing 1 to 20 of 40